Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Bulk Drug Intermediates >  PROSTAGLANDIN D2

PROSTAGLANDIN D2

Basic information Safety Supplier Related

PROSTAGLANDIN D2 Basic information

Product Name:
PROSTAGLANDIN D2
Synonyms:
  • 9,15-dihydroxy-11-oxo-,(5z,9-alpha,13e,15s)-prosta-13-dien-1-oicacid
  • prostaglandin D2 cell culture tested
  • prostaglandind2synthetichygroscopic
  • (5z,9α,13e,15s)-9,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic-acid
  • 7-[(1R,2R,5S)-5-hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid
  • PGD2, (5Z,9α,13E,15S)-9,15-Dihydroxy-11-oxoprosta-5,13-dien-1-oic-acid
  • (5Z,13E,15S)-9α,15-Dihydroxy-11-oxoprosta-5,13-dien-1-oic acid
  • Prostaglandin D2,(5Z,9α,13E,15S)-9,15-Dihydroxy-11-oxoprosta-5,13-dien-1-oic-acid, PGD2
CAS:
41598-07-6
MF:
C20H32O5
MW:
352.47
EINECS:
636-995-9
Mol File:
41598-07-6.mol
More
Less

PROSTAGLANDIN D2 Chemical Properties

Melting point:
68°C
Boiling point:
406.07°C (rough estimate)
alpha 
+7.5°(D/21℃)(c=1,THF)
Density 
1.0601 (rough estimate)
refractive index 
1.6120 (estimate)
storage temp. 
-20°C
solubility 
Chloroform (Slightly), Ethanol (Slightly), Methanol (Slightly), THF (Slightly)
pka
4.76±0.10(Predicted)
form 
White solid
color 
White to Light Orange
biological source
synthetic
BRN 
2170623
Stability:
Light Sensitive
More
Less

Safety Information

Hazard Codes 
T
Risk Statements 
60-22
Safety Statements 
53-22-26-36
WGK Germany 
3
RTECS 
UK7930000
10

MSDS

More
Less

PROSTAGLANDIN D2 Usage And Synthesis

Description

Prostaglandin D2 (PGD2) is the major eicosanoid product of mast cells and is released in large quantities during allergic and asthmatic anaphylaxis. Mastocytosis patients produce excessive amounts of PGD2, which causes vasodilation, flushing, hypotension, and syncopal episodes. PGD2 is also produced in the brain via an alternative pathway involving a soluble, secreted PGD-synthase also known as β-trace. In the brain, PGD2 produces normal physiological sleep and lowering of body temperature. Further pharmacological actions include inhibition of platelet aggregation and relaxation of vascular smooth muscle. PGD2 inhibits human ovarian tumor cell proliferation with an IC50 of 6.8 μM.

Uses

Prostaglandin D2 is a fatty acid compound present in the human body. Elevated levels of localized Prostaglandin D2 has been linked to hair loss and growth inhibition. It has also been seen to contribute to the activity of allergic asthma.

Definition

ChEBI: A member of the class of prostaglandins D that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9 and 15 and an oxo group at position 11 (the 5Z,9alpha,13E,15S- s ereoisomer).

Biochem/physiol Actions

Primary prostaglandin in brain; induces inflammation; stimulates adenylyl cyclase.

in vivo

Prostaglandin D2 (PGD2; infused into the lateral ventricle; 5-50 pmol/min; for 6 hours between 20:00 and 2:00) induces sleep-wake profiles in A2AR KO mice[2].

Animal Model:Male WT and A2AR KO mice of the inbred C57BL/6 strain (weighing 23-27 g, 11-13 weeks old)[1]
Dosage:5, 10, 20, or 50 pmol/min
Administration:Infused into the lateral ventricle; for 6 hours between 20:00 and 2:00
Result:Induced sleep-wake profiles.

IC 50

DP; Human Endogenous Metabolite

References

[1] L.JACKSON ROBERTS II  Brian J S. Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis[J]. Prostaglandins, 1985, 30 3: Pages 383-400. DOI: 10.1016/0090-6980(85)90114-5
[2] HAYAISHI O. Sleep-wake regulation by prostaglandins D2 and E2.[J]. The Journal of Biological Chemistry, 1988, 263 29: 14593-14596.
[3] H ONOE. Prostaglandin D2, a cerebral sleep-inducing substance in monkeys.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1988, 85 11: 4082-4086. DOI: 10.1073/pnas.85.11.4082
[4] Y KIKUCHI. Preclinical studies of antitumor prostaglandins by using human ovarian cancer cells.[J]. Cancer and Metastasis Reviews, 1994, 13 3-4: 309-315. DOI: 10.1007/bf00666101
[5] BRENDAN J. WHITTLE . Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: Treprostinil is a potent DP1 and EP2 agonist[J]. Biochemical pharmacology, 2012, 84 1: Pages 68-75. DOI: 10.1016/j.bcp.2012.03.012
[6] OYEBOLA O OYESOLA. The Prostaglandin D2 Receptor CRTH2 Promotes IL-33-Induced ILC2 Accumulation in the Lung.[J]. Journal of immunology, 2020, 204 4: 1001-1011. DOI: 10.4049/jimmunol.1900745
[7] AKIKO SUGANAMI. Human DP and EP2 prostanoid receptors take on distinct forms depending on the diverse binding of different ligands[J]. The FEBS journal, 2016, 283 21: 3931-3940. DOI: 10.1111/febs.13899
[8] D F WOODWARD. Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024).[J]. Journal of Pharmacology and Experimental Therapeutics, 2003, 305 2: 772-785. DOI: 10.1124/jpet.102.047837
[9] P. WAFFO-TéGUO. Potential Cancer-Chemopreventive Activities of Wine Stilbenoids and Flavans Extracted From Grape (Vitis vinifera) Cell Cultures[J]. Nutrition and Cancer-An International Journal, 2001, 40 1: 173-179. DOI: 10.1207/s15327914nc402_14

PROSTAGLANDIN D2Supplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Syntechem Co.,Ltd
Tel
Email
info@syntechem.com
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com